Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework
The emergence and spread of multidrug-resistant tuberculosis (MDR-TB), i.e. involving resistance to at least isoniazid and rifampicin, could threaten the control of TB globally. Controversy has emerged about the best way of confronting MDR-TB in settings with very limited resources. In 1999, the Wor...
Main Authors: | Pablos-Méndez Ariel, Gowda Deepthiman K., Frieden Thomas R. |
---|---|
Format: | Article |
Language: | English |
Published: |
The World Health Organization
2002-01-01
|
Series: | Bulletin of the World Health Organization |
Subjects: | |
Online Access: | http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862002000600015 |
Similar Items
-
Multidrug-resistant tuberculosis
by: Álvarez-Gaviria Manuel, et al.
Published: (2013-06-01) -
Culture conversion at six months in patients receiving bedaquiline- and delamanid-containing regimens for the treatment of multidrug-resistant tuberculosis
by: Shynar M. Maretbayeva, et al.
Published: (2021-12-01) -
The challenge of managing extensively drug-resistant tuberculosis at a referral hospital in the state of São Paulo, Brazil: a report of three cases
by: Marcos Abdo Arbex, et al.
Published: (2015-12-01) -
The Trend of Tuberculosis in Tekirdağ
by: Hayati Güneş, et al.
Published: (2015-04-01) -
Multidrug-resistant Tuberculosis Management in Resource-limited Settings
by: Eva Nathanson, et al.
Published: (2006-09-01)